Not applicableStudy completedNCT02862132
What this trial is testing
Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases
Who this might be right for
Crohn's DiseaseUlcerative ColitisInflammatory Bowel Disease
Shaare Zedek Medical Center 142